Phase 2/3 Study of IGSC, 20% in PIDD

Clinical trial NCT01218438 · COMPLETED

Trial details

NCT number: NCT01218438
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Immunodeficiency Diseases (PID)

Start date: 2013-01-28
Primary completion: 2015-03-13
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.